메뉴 건너뛰기




Volumn 30, Issue 9, 2010, Pages 3637-3642

The Wilms' tumor suppressor WT1 regulates expression of members of the Epidermal Growth Factor Receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance

Author keywords

Breast cancer; EGFR; Estrogen and antiestrogen; HER2; WT1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; SHORT HAIRPIN RNA; TAMOXIFEN; WT1 PROTEIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

EID: 77958574554     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (30)
  • 1
    • 0035101145 scopus 로고    scopus 로고
    • Cellular and molecular pharmacology of antiestrogen action and resistance
    • Clark RB, Leonessa F, Welch JN and Skaar TC: Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 53: 25-71, 2005.
    • (2005) Pharmacol Rev , vol.53 , pp. 25-71
    • Clark, R.B.1    Leonessa, F.2    Welch, J.N.3    Skaar, T.C.4
  • 3
    • 0034667395 scopus 로고    scopus 로고
    • Inhibition of HER2/neu (ERB-B2) and mitogen-activated protein kinases enhances tamoxifen action against HER-2 overexpressing, tamoxifen-resistant breast cancer cells
    • Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowske MX, Forbes JT and Arteaga CL: Inhibition of HER2/neu (ERB-B2) and mitogen-activated protein kinases enhances tamoxifen action against HER-2 overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res 60: 5887-5894, 2000.
    • (2000) Cancer Res , vol.60 , pp. 5887-5894
    • Kurokawa, H.1    Lenferink, A.E.2    Simpson, J.F.3    Pisacane, P.I.4    Sliwkowske, M.X.5    Forbes, J.T.6    Arteaga, C.L.7
  • 7
    • 0025098654 scopus 로고
    • Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
    • Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH and Bruns GA: Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990. (Pubitemid 120028613)
    • (1990) Nature , vol.343 , Issue.6260 , pp. 774-778
    • Gessler, M.1    Poustka, A.2    Cavenee, W.3    Neve, R.L.4    Orkin, S.H.5    Bruns, G.A.P.6
  • 9
    • 0035835816 scopus 로고    scopus 로고
    • Wilms' tumor and the WT1 gene
    • Lee SB and Haber DA: Wilms' tumor and the WT1 gene. Exp. Cell Res 264: 74-99, 2001.
    • (2001) Exp. Cell Res , vol.264 , pp. 74-99
    • Lee, S.B.1    Haber, D.A.2
  • 10
    • 0030891372 scopus 로고    scopus 로고
    • A clinical overview of WT1 gene mutations
    • Little M and Wells C: A clinical overview of WT1 gene mutations. Hum Mutat 9: 209-225, 1997.
    • (1997) Hum Mutat , vol.9 , pp. 209-225
    • Little, M.1    Wells, C.2
  • 16
    • 77949448448 scopus 로고    scopus 로고
    • The Wilms' tumor suppressor WT1 A-isoform induces estrogen independent growth and antiestrogen resistance in ER-positive breast cancer MCF7 cells
    • Wang L and Wang Z-Y: The Wilms' tumor suppressor WT1 A-isoform induces estrogen independent growth and antiestrogen resistance in ER-positive breast cancer MCF7 cells. Oncol Rep 23: 1109-1117, 2010.
    • (2010) Oncol Rep , vol.23 , pp. 1109-1117
    • Wang, L.1    Wang, Z.-Y.2
  • 17
    • 11244250660 scopus 로고    scopus 로고
    • Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: New opportunities for therapy
    • DOI 10.1677/erc.1.00778
    • Nicholson RI, Staka C, Boyns F, Hutcheson IR and Gee JMW: Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocr Relat Cancer 11: 623-641, 2004. (Pubitemid 40065542)
    • (2004) Endocrine-Related Cancer , vol.11 , Issue.4 , pp. 623-641
    • Nicholson, R.I.1    Staka, C.2    Boyns, F.3    Hutcheson, I.R.4    Gee, J.M.W.5
  • 19
    • 42049121934 scopus 로고    scopus 로고
    • Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
    • Grazia A, Wiechmann L, Osborne CK and Schiff R: Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev 29: 217-233, 2008.
    • (2008) Endocr Rev , vol.29 , pp. 217-233
    • Grazia, A.1    Wiechmann, L.2    Osborne, C.K.3    Schiff, R.4
  • 21
    • 34247579714 scopus 로고    scopus 로고
    • A tumor suppressor and oncogene: The WT1 story
    • DOI 10.1038/sj.leu.2404624, PII 2404624
    • Yang L, Han Y, Saiz FS and Minden MD: A tumor suppressor and oncogene: the WT1 story. Leukemia 21: 868-876, 2007. (Pubitemid 46672061)
    • (2007) Leukemia , vol.21 , Issue.5 , pp. 868-876
    • Yang, L.1    Han, Y.2    Saurez Saiz, F.3    Minden, M.D.4
  • 22
    • 0027286309 scopus 로고
    • The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains
    • Wang ZY, Qiu QQ and Deuel TF: The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Bio Chem 268: 9172-9175, 1993.
    • (1993) J Bio Chem , vol.268 , pp. 9172-9175
    • Wang, Z.Y.1    Qiu, Q.Q.2    Deuel, T.F.3
  • 23
    • 77949484047 scopus 로고    scopus 로고
    • The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells
    • Liu XW, Gong LJ, Guo LY, Katagiri Y, Jiang H, Wang ZY, Johnson AC and Guroff G: The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J Bio Chem 273: 27047-27050, 1998.
    • (1998) J Bio Chem , vol.273 , pp. 27047-27050
    • Liu, X.W.1    Gong, L.J.2    Guo, L.Y.3    Katagiri, Y.4    Jiang, H.5    Wang, Z.Y.6    Johnson, A.C.7    Guroff, G.8
  • 24
    • 4644244293 scopus 로고    scopus 로고
    • Transcriptional activation of c-myc proto-oncogene by WT1 protein
    • DOI 10.1038/sj.onc.1207609
    • Han Y, San-Marina S, Liu J and Minden MD: Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene 23: 6933-6941, 2004. (Pubitemid 39279994)
    • (2004) Oncogene , vol.23 , Issue.41 , pp. 6933-6941
    • Han, Y.1    San-Marina, S.2    Liu, J.3    Minden, M.D.4
  • 25
    • 0028844582 scopus 로고
    • Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1
    • Hewitt SM, Hamada S, McDonnell TJ, Rauscher III FJ and Saunders GF: Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 55: 5386-5389, 1995.
    • (1995) Cancer Res , vol.55 , pp. 5386-5389
    • Hewitt, S.M.1    Hamada, S.2    McDonnell, T.J.3    Rauscher III, F.J.4    Saunders, G.F.5
  • 28
    • 0023371106 scopus 로고
    • Human HER2 (neu) promoter: Evidence for multiple mechanisms for transcriptional initiation
    • Tal M, King CR, Kraus MH, Ullrich A, Schlessinger J and Givollt D: Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol Cell Biol 7: 2597-2601, 1987.
    • (1987) Mol Cell Biol , vol.7 , pp. 2597-2601
    • Tal, M.1    King, C.R.2    Kraus, M.H.3    Ullrich, A.4    Schlessinger, J.5    Givollt, D.6
  • 29
    • 52449108275 scopus 로고    scopus 로고
    • Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-α expression in breast cancer cells
    • Han, YQ, Lin Y, Suarez-Saiz F, San-Matina S, Cui J and Minden MD: Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-α expression in breast cancer cells. Mol Cancer Res 6: 1347-1355, 2008.
    • (2008) Mol Cancer Res , vol.6 , pp. 1347-1355
    • Han, Y.Q.1    Lin, Y.2    Suarez-Saiz, F.3    San-Matina, S.4    Cui, J.5    Minden, M.D.6
  • 30
    • 34249048667 scopus 로고    scopus 로고
    • Isoforms of Wilms' tumor suppressor (WT1) have distinct effects on mammary epithelial cells
    • Simpson LA, Thompson KA and Loeb DM: Isoforms of Wilms' tumor suppressor (WT1) have distinct effects on mammary epithelial cells. Oncogene 26: 3423-3430, 2007.
    • (2007) Oncogene , vol.26 , pp. 3423-3430
    • Simpson, L.A.1    Thompson, K.A.2    Loeb, D.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.